[LGND] YoY Quarter Result on 30-Sep-2010 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Nov-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- -4,084.81%
YoY- -756.85%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Revenue 13,005 6,375 5,741 7,802 7,901 5,248 5,479 15.48%
PBT 2,025 -52 -3,884 -11,436 1,055 -6,134 -7,222 -
Tax 60 142 22 419 -748 2,990 -2,360 -
NP 1,965 -194 -3,906 -11,843 1,803 -18,125 1,248 7.85%
Tax Rate -2.96% - - - 70.90% - - -
Total Cost 11,040 6,569 9,647 19,645 6,098 23,373 4,231 17.31%
Ratio Analysis
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
NP Margin 15.11 -3.04 -68.04 -151.79 22.82 -345.37 22.78 -6.60%
Per Share
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
EPS 0.10 -0.01 -0.20 -0.60 0.12 -1.14 0.06 8.87%
EPS Diluted 0.09 -0.01 -0.20 -0.60 0.12 -1.14 0.06 6.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.